Jane Street Group, LLC Provention Bio, Inc. Call Options Transaction History

Jane Street Group, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 16, 2022	SELL	$3.65 - $7.3 $1.36 Million - $2.71 Million	-371,400 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$3.4 - $7.88 $1.2 Million - $2.78 Million	353,300 Added 1951.93%	371,400 $2.72 Million
Q4 2021 Feb 15, 2022	SELL	$5.59 - $7.39 $39,130 - $51,730	-7,000 Reduced 27.89%	18,100 $102,000
Q3 2021 Nov 16, 2021	SELL	$5.66 - $8.33 $397,898 - $585,599	-70,300 Reduced 73.69%	25,100 $161,000
Q2 2021 Aug 16, 2021	BUY	$6.71 - $11.04 $104,676 - $172,224	15,600 Added 19.55%	95,400 $804,000
Q3 2020 Nov 17, 2020	SELL	$10.34 - $15.2 $561,462 - $825,360	-54,300 Reduced 40.49%	79,800 $1.02 Million
Q2 2020 Aug 17, 2020	BUY	$7.81 - $17.0 $1.05 Million - $2.28 Million	134,100 New	134,100 $1.89 Million

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.